Last update 21 Nov 2024

ZKAB-001/Icaritin(Lee's Pharmaceutical/Shenogen Pharma Group)

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
PD-L1 checkpoint inhibitor /ER-a36-inhibitor (Lee's Pharmaceutical/Shenogen Pharma Group)
Target
ERα x PDL1
Mechanism
ERα antagonists(Estrogen receptor alpha antagonists), PDL1 inhibitors(Programmed death-ligand 1 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
Lee's Pharmaceutical Holdings Ltd.Lee's Pharmaceutical Holdings Ltd.
Active Organization
The Johns Hopkins University School of MedicineThe Johns Hopkins University School of MedicineUniversity of IllinoisUniversity of Illinois
Inactive Organization
Lee's Pharmaceutical Holdings Ltd.Lee's Pharmaceutical Holdings Ltd.Beijing Shenogen Pharma Group Ltd.Beijing Shenogen Pharma Group Ltd.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with ZKAB-001/Icaritin(Lee's Pharmaceutical/Shenogen Pharma Group)
Login to view more data
100 Translational Medicine associated with ZKAB-001/Icaritin(Lee's Pharmaceutical/Shenogen Pharma Group)
Login to view more data
100 Patents (Medical) associated with ZKAB-001/Icaritin(Lee's Pharmaceutical/Shenogen Pharma Group)
Login to view more data
100 Deals associated with ZKAB-001/Icaritin(Lee's Pharmaceutical/Shenogen Pharma Group)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
CN
The Johns Hopkins University School of MedicineThe Johns Hopkins University School of Medicine
-
NeoplasmsPreclinical
CN
University of IllinoisUniversity of Illinois
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free